Results 121 to 130 of about 71,439 (210)

Association of erlotinib and acitretin for the treatment of Olmsted syndrome with erythromelalgia in a pediatric patient. [PDF]

An Bras Dermatol
Azulay-Abulafia L, Rodrigues Fagundes J, Ollague Cordova EE, Diniz Pacheco K, Hovnanian A.   +4 more
europepmc   +1 more source

Drug Interaction Between Erlotinib and Itraconazole in a Patient With Non-Small Cell Lung Cancer. [PDF]

Case Rep Oncol Med
Yokota H, Goshima S, Okuda Y, Sakamoto S, Takeda M, Sato K, Akamine Y, Nakayama K, Miura M.   +8 more
europepmc   +1 more source

Nano-Enabled Fluorescence Switching: A Novel Strategy for PDGFRβ Detection and TKI Therapy Monitoring. [PDF]

Research (Wash D C)
Fu X, Fan J, Chen H, Zheng Y, Liu Y, Zhang C, Cao X, Zuo T.   +7 more
europepmc   +1 more source

TRIPODD Enables Single-Cell Quantification of Therapeutic Efficacy. [PDF]

Mol Pharm
McMahon NP, Solanki A, Montaño AR, Ozdemir ES, Samkoe KS, Tichauer KM, Wang LG, Gibbs SL.   +7 more
europepmc   +1 more source

Rethinking maintenance strategies in biliary tract cancers. [PDF]

Transl Gastroenterol Hepatol
Grewal US, Brown TJ.
europepmc   +1 more source

Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Preclinical Pancreatic Cancer Models. [PDF]

Oncol Res
Gousseau P, Genest L, Froget G, Rupp T.
europepmc   +1 more source

«Pillnitzer interdisziplinäres Gespräch» – Zusammenfassung [PDF]

, 2006
Gatzemeier, Ulrich, Griesinger, Frank, Huber, Rudolf M.   +2 more
core   +1 more source

BRAF^V600E patient derived colon cancer organoids identify biomarkers of response to EGFR and BRAF inhibition and replicate clinical data. [PDF]

J Exp Clin Cancer Res
Kotarac A, Osumi H, Malt A, Alp KM, Jarosch A, Werner J, Benary M, Neumann CCM, Yao R, Mertins P, Eils R, Beule D, Sers C, Keilholz U, Ishaque N, Stintzing S, Vecchione L.   +16 more
europepmc   +1 more source

Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation [PDF]

, 2017
Galemmo, Robert A, Jr, Han, Zhenfu, Janetka, James W, Klampfer, Lidija, Owusu, Benjamin Y, Thomas, Shantasia, Venukadasula, Phanindra   +6 more
core   +2 more sources

Mechanism-based inactivation of human aldehyde oxidase by erlotinib: Mechanistic insights from structural analogs and molecular docking. [PDF]

Mol Pharmacol
Kweh JR, Ng NKM, Ngoh LM, Li CJY, Tan BJ, Tan WK, Mettu VS, Austin-Muttitt K, Mullins JGL, Lau AJ.   +9 more
europepmc   +1 more source